Table 2.
Group | Treatment | Dose | Duration of hind limb extensor phase (seconds) | % Mortality |
---|---|---|---|---|
I | Vehicle | 1 mL | 16.1 ± 0.75 | 72.33 |
II | Phenytoin | 20 mg/kg | 9.3 ± 0.7*** | 100** |
III | EESC | 100 mg/kg | 13.66 ± 0.91a | 94.33* |
IV | EESC | 200 mg/kg | 12.83 ± 0.60**b | 100** |
V | EESC | 400 mg/kg | 11.30 ± 0.33*** | 100** |
VI | EAF | 100 mg/kg | 12.33 ± 0.42**b | 100** |
VII | EAF | 200 mg/kg | 10.16 ± 0.70***b | 100** |
VIII | EAF | 400 mg/kg | 8.83 ± 0.30*** | 100** |
EESC: Ethanolic extract of Smilax china Linn.; EAF: Ethyl acetate fraction; Values are mean ± SEM (n =6). Statistical significance was determined by ANOVA, followed by Dunnett’s “t” test (n=6);
P < 0.001,
P < 0.01,
P < 0.05 when compared against control
P < 0.001,
P < 0.01,
when compared against standard